Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02570906 · ClinicalTrials.gov registry record
Performance Assessment of a Remote Patient Monitoring Device
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 12
- Enrollment target
NCT02570906: Completed study, sponsored by Medtronic - MITG.
NCT02570906 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02570906 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
This study will evaluate the performance of the Zephyr BioPatch in measuring heart rate, respiration rate, posture, and activity level compared to reference devices in healthy adult subjects during a variety of situations including hospital room movements, talking, and a short bout of exercise.
Primary Outcome
No follow-up visits will occur
Interventions
- DEVICE Zephyr BioPatch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-02 |
What the finished NCT02570906 record still lists
NCT02570906 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Zephyr BioPatch is the first listed.
NCT02570906 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02570906 about?
NCT02570906 is a clinical study titled "Performance Assessment of a Remote Patient Monitoring Device". This study will evaluate the performance of the Zephyr BioPatch in measuring heart rate, respiration rate, posture, and activity level compared to reference devices in healthy adult subjects during a variety of situations including hospital room movements, talking, and a short bout of exercise.
What is the current status of trial NCT02570906?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2015-12. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02570906?
The interventions under investigation include: Zephyr BioPatch (DEVICE).
Who is sponsoring clinical trial NCT02570906?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia